Uncategorized
Intravitreal sirolimus shows good results in treatment of noninfectious uveitis
NICE, France — Intravitreal sirolimus provides long-term resolution of posterior segment inflammation in patients with active noninfectious uveitis, according to the 1-year results of the SAKURA study. “[Noninfectious uveitis] of the posterior segment is in the vast majority of cases a chronic condition, requiring long-term treatment to prevent cumulative structural damage and vision loss,” Phuc Hoang, MD, PhD, said at the Euretina meeting.